Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Laron-Syndrom

Das Laron-Syndrom ist eine autosomal rezessive Erkrankung die durch loss-of-function mutationen im Wachstumshormon-Rezeptor (GHR) Gen hervorgerufen wird.

Klinischer Befund

Klinisch zeichnet sich das Krankheitsbild vor allem durch ein vermindertes Knochenwachstum und eine verzögerte Knochenreifung aus. Dabei sind Knochendysplasien nicht vorhanden.

Labortest

Die typische Laborkonstellation ist ein eher erhöhter Wachstumshormonspiegel bei deutlich erniedrigtem Somatomedin C Spiegel, auch bekannt als Insulin-ähnlicher Wachstumsfaktor 1 (IGF1). Der Spiegel des Wachstumshormon bindenden Proteins ist dagegen variabel ind Abhängigkeit von der Mutation. Nicht unerwähnt bleiben sollte eine Hypercholesterinämie, die mit Mutationen des Gens in Zusammenhang gebracht werden kann.

Gliederung

Wachstumshormon-Unempfindlichkeit
IGFBP3
Insulinähnlicher Wachtumsfaktor 1 Mangel
Insulinähnlicher Wachtumsfaktor 1 Resistenz
Insulinähnlicher Wachtumsfaktor 1-Transportproteinmangel
Laron-Syndrom
GHR
SH2B1
Wachstumshormoninsensitivität mit Immundefizit

Referenzen:

1.

Eshet R et al. (1984) Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.

external link
2.

Laron Z et al. (1988) Effect of acute administration of insulin-like growth factor I in patients with Laron-type dwarfism.

external link
3.

Pintor C et al. (1989) A child with phenotypic Laron dwarfism and normal somatomedin levels.

external link
4.

Geffner ME et al. (1987) Tissues of the Laron dwarf are sensitive to insulin-like growth factor I but not to growth hormone.

external link
5.

Keret R et al. (1988) Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.

external link
6.

Daughaday WH et al. (1987) Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).

external link
7.

Merimee TJ et al. (1968) An unusual variety of endocrine dwarfism: subresponsiveness to growth hormone in a sexually mature dwarf.

external link
8.

None (1974) Syndrome of familial dwarfism and high plasma immunoreactive growth hormone.

external link
9.

Daughaday WH et al. (1969) Defective sulfation factor generation: a possible etiological link in dwarfism.

external link
10.

Najjar SS et al. (1971) Dwarfism with elevated levels of plasma growth hormone.

external link
11.

Pertzelan A et al. () Genetic aspects of pituitary dwarfism due to absence or biological inactivity of growth hormone.

external link
12.

Golde DW et al. (1980) Peripheral unresponsiveness to human growth hormone in Laron dwarfism.

external link
13.

Phillips LS et al. (1980) Somatomedins (first of two parts).

external link
14.

Ayling RM et al. (1997) A dominant-negative mutation of the growth hormone receptor causes familial short stature.

external link
15.

Pierson M et al. (1978) [Laron type familial dwarfism; genetic primary somatomedin deficiency].

external link
16.

Saldanha PH et al. (1981) Familial dwarfism with high IR-GH: report of two affected sibs with genetic and epidemiologic considerations.

external link
17.

Laron Z et al. (1980) Puberty in Laron type dwarfism.

external link
18.

Schaefer GB et al. (1994) Facial morphometry of Ecuadorian patients with growth hormone receptor deficiency/Laron syndrome.

external link
19.

Souza SC et al. (1995) A single arginine residue determines species specificity of the human growth hormone receptor.

external link
20.

Hopwood NJ et al. (1993) Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.

external link
21.

Backeljauw PF et al. (1996) Prolonged treatment with recombinant insulin-like growth factor-I in children with growth hormone insensitivity syndrome--a clinical research center study. GHIS Collaborative Group.

external link
22.

Baumbach L et al. (1997) Clinical, biochemical, and molecular investigations of a genetic isolate of growth hormone insensitivity (Laron's syndrome).

external link
23.

Guevara-Aguirre J et al. (1997) Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: comparison of two dosage levels and to GH-treated GH deficiency.

external link
24.

Woods KA et al. (1997) Phenotype: genotype relationships in growth hormone insensitivity syndrome.

external link
25.

Zhou Y et al. (1997) A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse).

external link
26.

Pintor C et al. (1990) Correction and withdrawal of conclusion--a child with phenotypic Laron dwarfism and normal somatomedin levels.

external link
27.

Goddard AD et al. (1995) Mutations of the growth hormone receptor in children with idiopathic short stature. The Growth Hormone Insensitivity Study Group.

external link
28.

Rosenbloom AL et al. (1990) The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.

external link
29.

Arden KC et al. (1990) The receptors for prolactin and growth hormone are localized in the same region of human chromosome 5.

external link
30.

Barton DE et al. (1989) Chromosome mapping of the growth hormone receptor gene in man and mouse.

external link
31.

Amselem S et al. (1989) Laron dwarfism and mutations of the growth hormone-receptor gene.

external link
32.

Berg MA et al. (1993) Diverse growth hormone receptor gene mutations in Laron syndrome.

external link
33.

Woods KA et al. (1996) A homozygous splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein.

external link
34.

Laron Z et al. () Genetic pituitary dwarfism with high serum concentation of growth hormone--a new inborn error of metabolism?

external link
35.

Behncken SN et al. (1997) Aspartate 171 is the major primate-specific determinant of human growth hormone. Engineering porcine growth hormone to activate the human receptor.

external link
36.

Buchanan CR et al. (1991) Laron-type dwarfism with apparently normal high affinity serum growth hormone-binding protein.

external link
37.

Rosenbloom AL et al. (1999) Growth hormone receptor deficiency in Ecuador.

external link
38.

Mauras N et al. (2000) Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism.

external link
39.

Backeljauw PF et al. (2001) Therapy for 6.5-7.5 years with recombinant insulin-like growth factor I in children with growth hormone insensitivity syndrome: a clinical research center study.

external link
40.

Kastrup KW et al. (1975) Increased immunoreactive plasma and urinary growth hormone in growth retardation with defective generation of somatomedin a (Laron's Syndrome).

external link
41.

Laron Z et al. (1992) Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism.

external link
42.

Benbassat CA et al. (2003) Are adult patients with Laron syndrome osteopenic? A comparison between dual-energy X-ray absorptiometry and volumetric bone densities.

external link
43.

None (1992) Molecular biology of growth hormone receptor dysfunction.

external link
44.

None (2004) Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003.

external link
45.

Jacobs LS et al. (1976) Receptor-active growth hormone in Laron dwarfism.

external link
46.

Eicher EM et al. (1991) Growth hormone receptor (Ghr) and hemoglobin alpha-chain pseudogene 3 (Hba-ps3) map proximal to the myelocytomatosis oncogene (Myc) on mouse chromosome 15.

external link
47.

Walker JL et al. (1991) Effects of the infusion of insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron dwarfism).

external link
48.

Aguirre A et al. (1990) High-affinity serum growth-hormone-binding protein, absent in Laron-type dwarfism, is diminished in heterozygous parents.

external link
49.

Guevara-Aguirre J et al. (2011) Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans.

external link
50.

Laron Z et al. (1989) A child with phenotypic Laron dwarfism and normal somatomedin levels.

external link
51.

OMIM.ORG article

Omim 262500 external link
52.

Orphanet article

Orphanet ID 633 external link
53.

Wikipedia Artikel

Wikipedia DE (Laron-Syndrom) external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz